🦊/Companies

CellPly

Bologna, IT · Founded 2013 · 28 employees on LinkedIn · 3 known investors

Find your way into CellPly

304 people in our graph share verified history with the CellPly team — schools, employers, funds. One of them is your warm intro.

Rustyunlockedknows Massimo Bocchi · together at STMicroelectronics (overlapped)
knows the team · via STMicroelectronics
×7knows the team · via Santa Clara University Leavey School of Business
×3knows the team · via SDA Bocconi

Cellply develops VivaCyte, an automated platform that combines microfluidic consumables, an instrument, and image-analysis software to characterize cell therapies at single-cell resolution. It serves cell therapy discovery and development teams, measuring phenotype and function across thousands of single-cell co-cultures and comparing up to 128 conditions per run.

Founders & leadership

CellPly was founded in 2013 by Massimo Bocchi.

MBMassimo Bocchi
Massimo BocchiinCo-Founder & Chief Operating OfficerHe has spent over a decade in life science technology development, with research and publication record in microtechnologies for cell analysis, and holds multiple patents in the field. He has led commercialization efforts for deep tech platforms integrating microfluidics, robotics, and AI for biopharma and research institutions, and coordinated European research funding initiatives.
AZAlessia Zanelli
Alessia ZanelliinPresident & CEOZanelli previously served as General Manager of Comecer, an Italian healthcare-sector manufacturer, following the company's 2019 acquisition by Canadian industrial group ATS. She subsequently established a holding company in Milan focused on early-stage investing and has been involved with multiple health-tech startups including Cellply.
AFAndrea Faenza
Andrea FaenzainChief Technology Officer

Investors · 3

In the news

Frequently asked questions

What does CellPly do?
Cellply develops VivaCyte, an automated platform that combines microfluidic consumables, an instrument, and image-analysis software to characterize cell therapies at single-cell resolution. It serves cell therapy discovery and development teams, measuring phenotype and function across thousands of single-cell co-cultures and comparing up to 128 conditions per run.
Who founded CellPly?
CellPly was founded by Massimo Bocchi in 2013.
Who are CellPly's investors?
CellPly's investors include Indaco Venture Partners, Italian Angels for Growth, LIFTT.
Where is CellPly headquartered?
CellPly is headquartered in Bologna, IT.